vTv Therapeutics (VTVT)
32.24
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form DEFA14A vTv Therapeutics Inc.
June 10, 2026 4:11 PM - SEC Filing
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026 4:05 PM - StreetInsider
vTv Therapeutics (VTVT) PT Lowered to $45 at H.C. Wainwright
May 14, 2026 6:42 AM - StreetInsider
Form 424B2 vTv Therapeutics Inc.
May 13, 2026 5:22 PM - SEC Filing
Form 8-K vTv Therapeutics Inc. For: May 13
May 13, 2026 5:21 PM - SEC Filing
Form S-8 vTv Therapeutics Inc.
May 13, 2026 5:19 PM - SEC Filing
Form 10-Q vTv Therapeutics Inc. For: Mar 31
May 13, 2026 4:22 PM - SEC Filing
Form 8-K vTv Therapeutics Inc. For: May 13
May 13, 2026 4:20 PM - SEC Filing
vTv Therapeutics (VTVT) Tops Q1 EPS by 165c
May 13, 2026 4:19 PM - StreetInsider
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026 4:01 PM - StreetInsider
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 8, 2026 4:15 PM - StreetInsider
vTv Therapeutics to Participate in Upcoming May Investor Conferences
May 7, 2026 8:00 AM - Globe NewsWire
Form DEF 14A vTv Therapeutics Inc. For: Jun 10
April 28, 2026 4:22 PM - SEC Filing
Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
April 16, 2026 5:15 PM - SEC Filing
BTIG Reiterates Buy Rating on vTv Therapeutics (VTVT): 'VTVT checks every box'
April 13, 2026 12:29 PM - StreetInsider
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 7, 2026 4:15 PM - StreetInsider
Form SCHEDULE 13G vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
March 27, 2026 4:45 PM - SEC Filing
Full Article List
